by Jason Wasserman MD PhD FRCPC and Zuzanna Gorski MD
May 1, 2024
Atypical ductal hyperplasia (ADH) is a precancerous condition in the breast. A person with this condition has a 3- to 5-fold increased risk of developing a type of breast cancer called invasive ductal carcinoma in their lifetime. This condition starts from cells normally found inside small spaces called ducts.
No, atypical ductal hyperplasia is not a type of breast cancer. However, having this condition is associated with an increased chance of developing breast cancer in the future. Current studies suggest that a person diagnosed with atypical ductal hyperplasia is 3 to 5 times more likely to develop a type of breast cancer called invasive ductal carcinoma in their lifetime compared to someone who is not diagnosed with this condition. However, the overall risk of developing breast cancer with this condition alone is still low.
Most patients with atypical ductal hyperplasia do not have any symptoms. The condition is found when a breast imaging test such as mammography is performed. It cannot usually be felt as a lump in the breast unless it is associated with a tumour.
Atypical ductal hyperplasia is a hormone-sensitive disease, which means that the cells grow and divide in response to stimulation by hormones such as estrogen. For this reason, this condition is believed to be caused by the same genetic and environmental conditions that cause hormone-sensitive types of breast cancer.
Atypical ductal hyperplasia looks similar to low grade ductal carcinoma in situ (DCIS) when examined under the microscope. However, the area of the breast involved in this condition is smaller than DCIS and may not fill the entire duct. Because atypical ductal hyperplasia and DCIS look very similar, it can be very challenging for a pathologist to tell the difference between this condition and DCIS when a small tissue sample, such as a biopsy, is examined.
Atypical ductal hyperplasia is a proliferative lesion, indicating an increase in abnormal cells within the small spaces known as ducts. Pathologists often describe these cells as monotonous because they appear uniform (they look alike). Small calcium deposits, known as microcalcifications, may also be seen. When immunohistochemistry is performed, the abnormal cells are typically positive for estrogen receptor (ER) and progesterone receptor (PR), allowing them to respond to the hormones estrogen and progesterone.
Doctors wrote this article to help you read and understand your pathology report. Contact us with any questions about this article or your pathology report. Read this article for a more general introduction to the parts of a typical pathology report.